RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

The Centers for Medicare & Medicaid Services snuck new flu, RSV and COVID data-reporting requirements for nursing homes into ...

The Southwest Nebraska Public Health Department (SWNPHD) is urging residents to get vaccinated against Respiratory Syncytial Virus (RSV) and Influenza (flu) as respiratory virus season approaches.

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

Doctors are seeing more patients with respiratory virus symptoms, and the situation isn't likely to improve with the holidays ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose ...

The National Advisory Committee on Immunization (NACI) recommends vaccination against RSV for people in Canada aged 75 years and older, as well as those aged 60 years and older who are residents of ...